Cardiol Therapeutics Inc.
CRDL.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.84M | -9.33M | -4.82M | -6.81M | -5.61M |
| Total Depreciation and Amortization | 34.60K | 39.60K | 45.20K | 45.70K | 49.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.10M | 5.56M | 709.80K | 1.65M | -318.20K |
| Change in Net Operating Assets | 707.50K | -1.96M | 571.50K | -23.00K | 1.13M |
| Cash from Operations | -4.00M | -5.70M | -3.49M | -5.13M | -4.75M |
| Capital Expenditure | -4.40K | -5.80K | -2.80K | -2.60K | -7.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4.40K | -5.80K | -2.80K | -2.60K | -7.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -13.80K | -4.60K | -9.20K | -13.80K | -13.80K |
| Issuance of Common Stock | 21.36M | 0.00 | 87.30K | 90.20K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.65M | -- | -- | -- | -- |
| Cash from Financing | 13.35M | -3.40K | 57.10K | 56.60K | -10.20K |
| Foreign Exchange rate Adjustments | 1.15M | -260.00K | 109.40K | 364.30K | 647.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.50M | -5.97M | -3.33M | -4.72M | -4.12M |